💨 Abstract

Remedium Lifecare Ltd, a BSE-listed pharmaceutical company, has launched a rights issue to fund global expansion, strengthen its financial health, and invest in R&D. The issue, which has received a 26.03% subscription by the end of Day 2, will be used to enhance operational capabilities, tap global markets, and expand contract manufacturing in CDMO.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖